Hervé Van de Poël
Charles River Laboratories (United Kingdom)(GB)
Publications by Year
Research Areas
Crystallization and Solubility Studies, X-ray Diffraction in Crystallography, Viral Infections and Immunology Research, Synthesis and Reactivity of Heterocycles, Asthma and respiratory diseases
Most-Cited Works
- → A Novel, Broad-Spectrum Inhibitor of Enterovirus Replication That Targets Host Cell Factor Phosphatidylinositol 4-Kinase IIIβ(2013)114 cited
- → Synthesis of 6,7,8,9-tetrahydropyrido[2,3- b ]indolizine and 3,4-dihydro-2 H -pyrido[2′,3′:4,5]pyrrolo[2,1- b ][1,3]oxazine derivatives as new melatonin receptor ligands(2002)45 cited
- → Discovery of a Highly Selective, Brain-Penetrant Aminopyrazole LRRK2 Inhibitor(2012)44 cited
- → Identification of a Series of Compounds with Potent Antiviral Activity for the Treatment of Enterovirus Infections(2013)44 cited
- → Non-covalent inhibitors of rhinovirus 3C protease(2010)33 cited
- → Necrotizing Pneumonia in a Cat Caused by an Orthopox Virus(1999)26 cited
- → Synthesis of Melatonin Analogues Derived from Furo[2,3-b]- and [2,3-c]pyridines by Use of a Palladium-Copper Catalyst System(2002)25 cited
- → Discovery of M3 Antagonist-PDE4 Inhibitor Dual Pharmacology Molecules for the Treatment of Chronic Obstructive Pulmonary Disease(2021)10 cited
- → Optimization of M3 Antagonist–PDE4 Inhibitor (MAPI) Dual Pharmacology Molecules for the Treatment of COPD(2023)5 cited
- Synthese et proprietes pharmacologiques de ligands melatoninergiques a structure furo- et pyrrolopyridinique(2000)